Used in pharmaceutical research as a key intermediate in the synthesis of selective receptor modulators targeting central nervous system disorders. Shows potential in the development of compounds for treating anxiety, depression, and neurodegenerative conditions due to its ability to cross the blood-brain barrier and interact with monoaminergic pathways. Also employed in structure-activity relationship studies to optimize pharmacokinetic properties of novel therapeutics.